Article

A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquine

2023-06-28

Abstract excerpt

The COVID-19 pandemic necessitated a rapid mobilization of resources toward the development of safe and efficacious vaccines and therapeutics. Finding effective treatments to stem the wave of infected individuals needing hospitalization and reduce the risk of adverse events was paramount. For scientists and healthcare professionals addressing this challenge, the need to rapidly identify medical countermeasures bec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5c7072f9-d782-5e21-a440-4f6195dc31df
DOI: 10.1101/2023.06.27.546790

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquineDOI 10.1101/2023.06.27.546790Read

Development of robust antiviral assays using relevant apical-out human airway organoidsSemantic proximity Read

Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 InfectionSemantic proximity Read

Dynamic Culture Improves the Predictive Power of Bronchial and Alveolar Airway Models of SARS-CoV-2 InfectionSemantic proximity Read

High Throughput Screening with a Primary Human Mucociliary Airway Model Identifies a Small Molecule with Anti-SARS-CoV-2 ActivitySemantic proximity Read

An <i>ex vivo</i> human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacySemantic proximity Read

Adult Stem Cell-derived Complete Lung Organoid Models Emulate Lung Disease in COVID-19Semantic proximity Read

Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 InfectionSemantic proximity Read

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung OrganoidsSemantic proximity Read

Recapitulating SARS-CoV-2 Infection in a Human Lung Organoid-on-a-Chip at the Air-Liquid InterfaceSemantic proximity Read

SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variantsSemantic proximity Read

Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responsesSemantic proximity Read

SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responsesSemantic proximity Read